Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes. Jagarlapudi SP. N Engl J Med 2025;393:2276.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jagarlapudi SP. Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes. N Engl J Med 2025;393:2276.
PMID: 41337726